THERMO FISHER SCIENTIFIC INC. lobbying for THERMO FISHER SCIENTIFIC INC

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$430,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

JENNA CARMEN New on this filing

Previously held: Staff Assistant and Intern, Sen. Bob Casey, Jr.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 12

Centers For Medicare and Medicaid Services (CMS)
Commerce, Dept of (DOC)
Food & Drug Administration (FDA)
General Services Administration (GSA)
Health & Human Services, Dept of (HHS)
Homeland Security, Dept of (DHS)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE
Treasury, Dept of
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 3543
College for All Act of 2025
HR 5304
Extending Government Funding and Delivering Emergency Assistance Act
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Lobbying activity 7

Health Issues

General discussions related to clinical trials infrastructure and government labs. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 3543: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. Executive Order 14336: Ensuring American Pharmaceutical Supply Chain Resilience By Filling the Strategic Active Pharmaceutical Ingredients Reserve - all provisions of the order.

Budget/Appropriations

H.R. 5304/S. 2587: FY26 NIH Funding General discussions regarding government efficiency opportunities and government contract thresholds

Homeland Security

Preparedness products and services P.L. 91-513: Issues related to the Controlled Substances Act General discussions around government contracting opportunities

Law Enforcement/Crime/Criminal Justice

POWER Act; all provisions of the bill.

Trade (domestic/foreign)

General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.

Taxation/Internal Revenue Code

General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities

Labor Issues/Antitrust/Workplace

General discussions regarding impact of U.S. federal government workforce changes on industry